+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Women's Health - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 467 Pages
  • August 2020
  • Region: Global
  • GlobalData
  • ID: 5135641
Summary

The Medical Devices sector report, “Women’s Health - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Women’s Health pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Women’s Health that focuses on the treatment and diagnosis of diseases and conditions that affect a woman's physical and emotional well-being.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Women’s Health under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Women’s Health and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Women’s Health under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

Introduction
  • Women's Health Overview

Products under Development
  • Women's Health - Pipeline Products by Stage of Development
  • Women's Health - Pipeline Products by Territory
  • Women's Health - Pipeline Products by Regulatory Path
  • Women's Health - Pipeline Products by Estimated Approval Date
  • Women's Health - Ongoing Clinical Trials

Women's Health - Pipeline Products under Development by Companies
  • Women's Health Companies - Pipeline Products by Stage of Development
  • Women's Health - Pipeline Products by Stage of Development

Women's Health Companies and Product OverviewWomen's Health- Recent Developments
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
Table 1: Women's Health - Pipeline Products by Stage of Development
Table 2: Women's Health - Pipeline Products by Territory
Table 3: Women's Health - Pipeline Products by Regulatory Path
Table 4: Women's Health - Pipeline Products by Estimated Approval Date
Table 5: Women's Health - Ongoing Clinical Trials
Table 6: Women's Health Companies - Pipeline Products by Stage of Development
Table 7: Women's Health - Pipeline Products by Stage of Development
Table 8: AblaCare Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Women's Health - Pipeline Products by Stage of Development
Figure 2: Women's Health - Pipeline Products by Territory
Figure 3: Women's Health - Pipeline Products by Regulatory Path
Figure 4: Women's Health - Pipeline Products by Estimated Approval Date
Figure 5: Women's Health - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AblaCare
  • AdneXXA LLC
  • Advanced Prenatal Therapeutics, Inc.
  • Advanced Tactile Imaging Inc
  • Aethlon Medical Inc
  • Agile Therapeutics Inc
  • Allergan Ltd
  • AltaScience Limited
  • Alydia Health Inc
  • Amniotix Technologies Ltd
  • ANALYTICA PTY LTD
  • Aneeve Nanotechnologies LLC
  • Aspivix SA
  • Bayer AG
  • Baystate Medical Center
  • Becton Dickinson and Co
  • BeFree!
  • BellaSeno GmbH
  • Bioceptive Inc
  • BiolMed Innovations Pvt Ltd
  • Biorings LLC
  • Biostruxs LLC
  • BioTex Inc
  • Birmont Medical Ltd.
  • Bloomlife, Inc.
  • Cambridge Consultants Ltd
  • Cambridge Design Partner Ltd.
  • Cath Med Ltd.
  • Ceragenix Pharmaceuticals, Inc. (Inactive)
  • CervoCheck, LLC
  • Citius Pharmaceuticals LLC
  • CommonSense Ltd.
  • Contrel Europe NV
  • Dare Bioscience Inc
  • Dartmouth College
  • DermaDiagnostics
  • Discreet Secrete Solutions
  • DS Labs, Inc
  • Earth Science Tech Inc
  • Emory University
  • Enox Biopharma Inc (Inactive)
  • EVE Medical Systems Ltd
  • Evestra Inc
  • Evofem Biosciences Inc
  • Fannin Partners LLC
  • Femasys Inc
  • FemSuite LLC
  • Ferring Pharmaceuticals AS
  • Fibro Control (Israel) Ltd (Inactive)
  • Fotona LLC
  • FP Medtech Inc
  • Global Health Partnerships
  • Grunenthal Ltd
  • Haemek Medical Center
  • Healingstone Co Ltd
  • Healthcare Enterprise Group PLC (Inactive)
  • Hera Health Solutions
  • Hera Med Ltd
  • Herbio Co Ltd
  • HLL Lifecare Ltd
  • Hong Kong Polytechnic University
  • IcosaMed Sarl
  • Igantia Therapeutics
  • Imperial College London
  • Impres Medical, Inc.
  • In Veritas Medical Diagnostics Inc (Inactive)
  • Innometrix
  • INVO Bioscience Inc
  • J3 Bioscience Inc
  • Janitri Innovations Pvt Ltd
  • Jibon Health Technologies, Inc.
  • Johns Hopkins University
  • Joylux Inc
  • Keratin Biosciences Inc
  • KynderMed Inc
  • Laboratoire HRA Pharma SAS
  • Laboratorios Andromaco
  • Lady Technologies Inc
  • LifeCell Corp
  • Lyra Medical Ltd
  • Madorra
  • Magee-Womens Research Institute
  • Materna Medical Inc.
  • Maziwa
  • McGill University Health Center
  • Medela AG
  • MEDITE Cancer Diagnostics Inc
  • Medprin Regenerative Medical Technologies Co Ltd
  • MenoPal
  • Merck & Co Inc
  • Merck KGaA
  • Merck Serono SA
  • MFB Fertility Inc
  • Miltenyi Biotec GmbH
  • Mithra Pharmaceuticals SA
  • Momtec Life Ltd.
  • Myant Inc
  • Nagasaki University
  • NipaYe
  • Nipro Corp
  • Northwestern University
  • Novela Inc
  • Noventure SL
  • Novomedics L L C
  • OB Smart Ltd
  • ObsteCare AB
  • OCON Medical Ltd
  • OmniBiome Therapeutics Inc
  • OncoGenesis
  • Ondine Biomedical Inc
  • Onko Solutions, LLC
  • OOVA Inc
  • ORATEL DIAGNOSTICS LLC
  • Orion Biotechnology Canada Ltd
  • Os Technology LLC
  • Otago Innovation Ltd
  • PearlPod LLC
  • PEPTONIC medical AB
  • Pfizer Inc
  • Polumiros Inc
  • Polytechnic University of Catalonia
  • Positive Care Ltd
  • PregnanTech Ltd
  • Prima-Temp, Inc
  • Purdue University
  • Qurasense Inc
  • Rambam Health Care Campus
  • Reia LLC
  • Renovia Inc
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • RevMedx, Inc.
  • Rice University
  • Sebela Pharmaceuticals
  • Soulor Surgical Inc (Inactive)
  • Stanford University
  • Starpharma Holdings Ltd
  • Tecuro AG
  • Tentan AG
  • TeVido BioDevices LLC
  • The Cooper Companies Inc
  • The Feinstein Institute for Medical Research
  • TruScreen Ltd
  • University of Auckland
  • University of California San Francisco
  • University of Duisburg-Essen
  • University of Erlangen-Nurnberg
  • University of Florida
  • University of Liverpool
  • University of Maryland Baltimore
  • University of Minnesota
  • University of Pittsburgh
  • University of Sheffield
  • University of South Florida
  • University of Texas Health Science Center at San Antonio
  • University of Utah
  • University of Waterloo
  • VeriTeQ Corporation
  • Virginia Commonwealth University
  • VivoPlex Ltd
  • Wave Intelligence Inc
  • Willow Women's Clinic
  • Yale University
  • Zambon Italia Srl
  • ZR-Operculum, Inc.